IV JZP-458

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)NCT04145531Jazz PharmaceuticalsPhase 2, Phase 3Completed2022-07-13Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.